As of 2024-12-11, the Relative Valuation of Crescita Therapeutics Inc (CTX.TO) is (0.35) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 CAD, the upside of Crescita Therapeutics Inc based on Relative Valuation is -164.2%.
The range of the Relative Valuation is (0.29) - (0.42) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.0x - 3.0x | 2.5x |
| Forward P/E multiples | 2.0x - 2.9x | 2.4x |
| Fair Price | (0.29) - (0.42) | (0.35) |
| Upside | -151.9% - -176.3% | -164.2% |
| Date | P/E |
| 2024-12-06 | -3.85 |
| 2024-12-05 | -3.85 |
| 2024-12-04 | -3.85 |
| 2024-12-02 | -3.85 |
| 2024-11-29 | -4.06 |
| 2024-11-28 | -4.20 |
| 2024-11-27 | -4.20 |
| 2024-11-26 | -4.34 |
| 2024-11-22 | -4.48 |
| 2024-11-21 | -4.34 |
| 2024-11-19 | -4.06 |
| 2024-11-14 | -3.99 |
| 2024-11-13 | -4.20 |
| 2024-11-12 | -3.92 |
| 2024-11-11 | -3.99 |
| 2024-11-08 | -4.06 |
| 2024-11-06 | -4.06 |
| 2024-11-04 | -4.20 |
| 2024-11-01 | -4.06 |
| 2024-10-31 | -4.13 |
| 2024-10-30 | -4.13 |
| 2024-10-29 | -4.20 |
| 2024-10-28 | -4.20 |
| 2024-10-25 | -4.20 |
| 2024-10-24 | -4.34 |
| 2024-10-23 | -4.27 |
| 2024-10-22 | -4.06 |
| 2024-10-21 | -4.20 |
| 2024-10-18 | -3.99 |
| 2024-10-17 | -3.92 |
| 2024-10-16 | -3.92 |
| 2024-10-11 | -3.99 |
| 2024-10-09 | -3.99 |
| 2024-10-08 | -4.13 |
| 2024-10-07 | -4.13 |
| 2024-10-04 | -4.13 |
| 2024-10-03 | -4.20 |
| 2024-10-02 | -4.20 |
| 2024-10-01 | -4.20 |
| 2024-09-30 | -4.20 |
| 2024-09-27 | -4.13 |
| 2024-09-26 | -4.20 |
| 2024-09-24 | -4.27 |
| 2024-09-23 | -4.34 |
| 2024-09-20 | -4.34 |
| 2024-09-18 | -4.13 |
| 2024-09-17 | -4.20 |